Price $154.37 |
Market Cap
398.67B
|
Sector Health Care |
Div. Growth
6.20%
|
|
P/E
23.0
|
P/B
5.28
|
P/S
4.27
|
Dividend %
2.90%
|
|
P/CF
-
|
P/FCF
75.0
|
Op. Cash Flow
21.19M
|
FCF
2.0
|
|
Op. Margin
22.90%
|
Net Margin
18.90%
|
ROE
23.70%
|
ROI
15.40%
|
|
ROA
10.00%
|
EPS Growth
-13.50%
|
Current Ratio
1.0
|
Debt/Equity
35.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals, In (CPIX) | $1.59 | - | - | 28M | Strong Buy |
| Medicine Man Technologies Inc (SHWZ) | $1.01 | - | - | 59.4M | Strong Buy |
| Spero Therapeutics Inc (SPRO) | $1.77 | - | - | 74.6M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $3.66 | - | - | 191M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.27 | - | - | 16.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
